Current role
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
A. Ernest Toth
Equibles does not estimate personal net worth.
Get an email with a short summary when Aquestive Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get AQST alertsAbout A. Ernest Toth
A. Ernest Toth is recorded as CFO at Aquestive Therapeutics, Inc. (AQST). The newest filing on record that lists A. Ernest Toth as CFO at Aquestive Therapeutics, Inc. (AQST) is dated April 24, 2026. The proxy statement of Aquestive Therapeutics, Inc. reports total compensation of $1,323,547 for A. Ernest Toth in fiscal 2025, including a base salary of $442,599. Disclosed compensation is on record for 2 fiscal years. Aquestive Therapeutics, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Aquestive Therapeutics, Inc. includes Daniel Barber (CEO and Board Member), Gregory B. Brown (Chairman), John S. Cochran (Chairman) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 24, 2026
Company network
Leadership on record at Aquestive Therapeutics, Inc.
- Daniel Barber CEO, Board Member
- Gregory B. Brown Chairman
- John S. Cochran Chairman
- A. Ernest Toth, Jr. CFO
- Cassie Jung COO
- Thomas A. Zalewski General Counsel
- Abigail L. Jenkins Board Member
- Julie Krop Board Member
- Marco Taglietti Board Member
- Richard J. Daly Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Aquestive Therapeutics, Inc. (AQST) | Chief Financial Officer\ \ | $442,599 | $1,323,547 |
| 2021 | Aquestive Therapeutics, Inc. (AQST) | Chief Financial Officer\ | $467,529 | $1,059,642 |
Recent activity
No call appearances or filed executive changes recorded yet.